(Q53621236)

English

Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

1 reference

based on heuristic

inferred from title

acute myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

author name string

Sonja Schiffer

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Reinhard Rosinke

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Edgar Jost

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Grit Hehmann-Titt

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Michael Huhn

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Georg Melmer

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

Theo Thepen

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

language of work or name

0 references

publication date

18 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

135

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

1497-1508

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Delivery and therapeutic potential of human granzyme B.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

HER2-targeting recombinant protein with truncated pseudomonas exotoxin A translocation domain efficiently kills breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Fcgamma receptor 1 (CD64), a target beyond cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Laboratory diagnosis of chronic myelomonocytic leukemia and progression to acute leukemia in association with chronic lymphocytic leukemia: morphological features and immunophenotypic profile

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Clonal architecture of chronic myelomonocytic leukemias

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Efficient Nuclear Targeting of Granzyme B and the Nuclear Consequences of Apoptosis Induced by Granzyme B and Perforin Are Caspase-dependent, but Cell Death Is Caspase-independent

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Design of human granzyme B variants resistant to serpin B9

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28786

21 January 2018

Identifiers

10.1002/IJC.28786

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

release_e4hhzmzdxfgqnj2k5ny4qiimh4

1 reference

https://api.fatcat.wiki/v0/release/e4hhzmzdxfgqnj2k5ny4qiimh4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/24523193

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53621236&oldid=1840035584"